India's fastest woman, Dutee Chand, who was handed a four year ban for failing two out-of-competition dope tests in December of 2022, has decided to appeal the National Anti-Doping Agency (NADA) decision.
Dutee's samples were found positive for selective androgen receptor modulators (SARMs) and her ban period started on 3 December 2023.
According to United States Anti-Doping Agency (USADA), SARMs are a class of therapeutic compounds that have similar anabolic properties to anabolic steroids, but with reduced androgenic (producing male characteristics) properties. SARMs are listed in the category of "Other Anabolic Agents" under section S1.2 of the WADA Prohibited List.
Dutee has been out of action since January this year when she was provisionally suspended after her samples returned positive.
(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)